US-guided Trocar Versus Seldiger Technique for Percutaneous Cholecystostomy
- Conditions
- Cholecystitis
- Interventions
- Procedure: Seldinger percutaneous cholecystostomyProcedure: Trocar percutaneous cholecystostomy
- Registration Number
- NCT04602156
- Lead Sponsor
- Attikon Hospital
- Brief Summary
A single-center randomized comparison of bedside ultrasound (US)-guided trocar technique versus the US-guided Seldinger technique for percutaneous cholecystostomy
- Detailed Description
This is a single-center, randomized, controlled trial (RCT), comparing bedside US-guided trocar technique versus the US-guided Seldinger technique for percutaneous cholecystostomy (PC). The study will randomize a total of 100 consecutive patients (50 in each group) undergoing PC at one large tertiary university hospital. The primary endpoints will be technical success and procedure-related complication rates. Secondary endpoints will be procedural duration, pain assessment, and clinical success after up to 3 months of follow-up.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- All patients requiring PC, regardless of the underlying cause.
- Signed informed consent form
- Age <18 years or >100 years
- The necessity for CT-guided PC catheter placement, according to the judgment of the performing physician
- Severe uncontrollable coagulopathy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group S Seldinger percutaneous cholecystostomy Patients will be randomized to undergo PC catheter placement (8-French) using the Sellinger method under US guidance while receiving local anesthesia and opioid analgesic, in a bedside setting, either in the US room or in the ICU. Group T Trocar percutaneous cholecystostomy Patients will be randomized to undergo PC catheter placement (8-French) using the trocar method under US guidance while receiving local anesthesia and opioid analgesic, in a bedside setting, either in the US room or in the ICU.
- Primary Outcome Measures
Name Time Method Technical success At the end of the procedure Image verified catheter placement within the gallbladder and subsequent bile aspiration
Procedure-related complications 3 months Minor or major complications attributed to the procedure
- Secondary Outcome Measures
Name Time Method Clinical success 72 hours Gradual subsidence of signs, symptoms, and elevated inflammatory markers
Duration of the procedure Intraprocedural The time period between administration of local anesthesia and pigtail catheter positioning within the gallbladder
Intraprocedural pain End of the procedure pain experienced during the procedure assessed using a standard visual analogue score the procedure, as assessed using a standard visual analog score
Post-procedural pain 12 hours Pain experienced up to12 hours after procedure assessed using a standard visual analogue score (VAS - Visual Analog Scale 0-10, 0 representing no pain \& 10 representing worst pain experienced)
Trial Locations
- Locations (1)
"Attikon" University General Hospital
🇬🇷Athens, Attiki, Greece